411 related articles for article (PubMed ID: 20855493)
1. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ
J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.
Coulthart MB; Jansen GH; Olsen E; Godal DL; Connolly T; Choi BC; Wang Z; Cashman NR
BMC Neurol; 2011 Oct; 11():133. PubMed ID: 22032272
[TBL] [Abstract][Full Text] [Related]
4. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
[TBL] [Abstract][Full Text] [Related]
5. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.
Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
J Neurol; 2016 Sep; 263(9):1847-61. PubMed ID: 27357003
[TBL] [Abstract][Full Text] [Related]
6. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.
Sanchez-Juan P; Sánchez-Valle R; Green A; Ladogana A; Cuadrado-Corrales N; Mitrová E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Krasnianski A; Equestre M; Slivarichová D; Saiz A; Calero M; Pocchiari M; Knight R; van Duijn CM; Zerr I
J Neurol; 2007 Jul; 254(7):901-6. PubMed ID: 17385081
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease.
Zanusso G; Fiorini M; Ferrari S; Gajofatto A; Cagnin A; Galassi A; Richelli S; Monaco S
Int J Mol Sci; 2011; 12(9):6281-92. PubMed ID: 22016658
[TBL] [Abstract][Full Text] [Related]
8. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
[TBL] [Abstract][Full Text] [Related]
9. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.
Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
[TBL] [Abstract][Full Text] [Related]
11. Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis.
Gawinecka J; Ciesielczyk B; Sanchez-Juan P; Schmitz M; Heinemann U; Zerr I
Neurodegener Dis; 2012; 9(3):139-44. PubMed ID: 22213780
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.
Bahl JM; Heegaard NH; Falkenhorst G; Laursen H; Høgenhaven H; Mølbak K; Jespersgaard C; Hougs L; Waldemar G; Johannsen P; Christiansen M
Neurobiol Aging; 2009 Nov; 30(11):1834-41. PubMed ID: 18339451
[TBL] [Abstract][Full Text] [Related]
13. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
[TBL] [Abstract][Full Text] [Related]
14. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.
Green AJ; Thompson EJ; Stewart GE; Zeidler M; McKenzie JM; MacLeod MA; Ironside JW; Will RG; Knight RS
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):744-8. PubMed ID: 11385008
[TBL] [Abstract][Full Text] [Related]
15. Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel.
Meiner Z; Kahana E; Baitcher F; Korczyn AD; Chapman J; Cohen OS; Milo R; Aharon-Perez J; Abramsky O; Gabizon R; Rosenmann H
J Neurol; 2011 Feb; 258(2):255-62. PubMed ID: 20827556
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt-Jakob disease.
Gmitterová K; Heinemann U; Krasnianski A; Gawinecka J; Zerr I
Eur J Neurol; 2016 Jun; 23(6):1126-33. PubMed ID: 27029507
[TBL] [Abstract][Full Text] [Related]
17. High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD.
Fiorini M; Iselle G; Perra D; Bongianni M; Capaldi S; Sacchetto L; Ferrari S; Mombello A; Vascellari S; Testi S; Monaco S; Zanusso G
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019068
[TBL] [Abstract][Full Text] [Related]
18. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs.
Llorens F; Karch A; Golanska E; Schmitz M; Lange P; Sikorska B; Liberski PP; Zerr I
Dement Geriatr Cogn Disord; 2017; 43(1-2):71-80. PubMed ID: 28056460
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and specificity evaluation of multiple neurodegenerative proteins for Creutzfeldt-Jakob disease diagnosis using a deep-learning approach.
Lee SM; Hyeon JW; Kim SJ; Kim H; Noh R; Kim S; Lee YS; Kim SY
Prion; 2019 Jan; 13(1):141-150. PubMed ID: 31306078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]